Mualliflar

  • Saidburxon Qo‘chqorxo‘jayev
    Kokand Universiteti Andijon filiali

DOI:

https://doi.org/10.71337/inlibrary.uz.universaljurnal.110955

Kalit so‘zlar:

Genetik tahrir gen terapiyasi immunoterapiya onkogenez genomni manipulyatsiya qilish molekulyar biotexnologiya

Annotasiya

Ushbu maqolada CRISPR-Cas9 texnologiyasining saraton kasalligini davolashdagi
imkoniyatlari,uning qanday ishlash mexanizmlari keltirilgan. Maqola, CRISPR-Cas9 tizimining
genomni aniq tahrirlash imkoniyatlarini, uning saraton kasalligi uchun terapiya sifatida qanday
ishlatilishi mumkinligini yoritib beradi. Texnologiyaning genetik manipulyatsiya, gen
terapiyasi,immunoterapiya sohalarida qo‘llanilishi, shuningdek, saraton hujayralarini aniqlash va
yo‘q qilishdagi yutuqlari muhokama qilinadi.


background image

background image

background image

background image

Bibliografik manbalar

Jinek, M., & Doudna, J. A. (2012). A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity. Science, 337(6096), 816-821. https://doi.org/10.1126/science.1225829

Zhang, F., Wen, Y., & Guo, X. (2014). Crispr/Cas9 for Genome Editing: Progress, Implications, and Applications. Journal of Human Genetics, 59(6), 342-349. https://doi.org/10.1038/jhg.2014.30

Sander, J. D., & Joung, J. K. (2014). CRISPR-Cas Systems for Editing, Regulating and Targeting Genomes. Nature Biotechnology, 32(4), 347-355. https://doi.org/10.1038/nbt.2842

Zetsche, B., Gootenberg, J. S., & Abudayyeh, O. O. (2015). Crispr-Cas9 Genome Editing in Human Cells: A Practical Guide. Trends in Biotechnology, 33(4), 293-299. https://doi.org/10.1016/j.tibtech.2015.02.003

Ma, H., & Zhang, L. (2019). CRISPR/Cas9-based Genome Editing: The Role of Targeted DNA Repair in Cancer Therapy. Cancer Research, 79(10), 2680-2689. https://doi.org/10.1158/0008-5472.CAN-18-3413